Sinaptica Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $25M

  • Investors
  • 19

Sinaptica Therapeutics General Information

Description

Operator of a non-invasive personalized neuromodulation platform intended to support the treatment of Alzheimer's. The company offers technology that induces neuroplasticity, strengthens the brain's key memory network and is protected by broad patents, enabling individuals affected by Alzheimer's, through personalized therapeutic support, to experience a measurable slowing of disease progression.

Contact Information

Website
www.sinapticatx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 245 First Street
  • 18th Floor
  • Cambridge, MA 02142
  • United States
+1 (800)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 245 First Street
  • 18th Floor
  • Cambridge, MA 02142
  • United States
+1 (800)

Sinaptica Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sinaptica Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC $25M Completed Clinical Trials - Phase 2
6. Early Stage VC 02-Jul-2025 Completed Clinical Trials - Phase 2
5. Accelerator/Incubator 06-Jun-2025 Completed Clinical Trials - Phase 2
4. Accelerator/Incubator 01-Jan-2025 Completed Clinical Trials - Phase 2
3. Accelerator/Incubator 04-Mar-2024 Completed Startup
2. Seed Round 30-Sep-2023 $1.6M $1.6M Completed Startup
1. Accelerator/Incubator Completed Startup
To view Sinaptica Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Sinaptica Therapeutics Patents

  • 20

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 12

    Pending

  • Expiring in next 12 mo

Sinaptica Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260241190-A1 Systems and methods to assess neurodegeneration in a patient using non-invasive stimulation Pending 29-Jun-2022
AU-2023298639-A1 Systems and methods to characterize individual response to brain perturbation in patients with alzheimer's disease Pending 29-Jun-2022
EP-4547108-A2 Systems and methods to characterize individual response to brain perturbation in patients with alzheimer's disease Pending 29-Jun-2022
EP-4547108-A4 Systems and methods to characterize individual response to brain perturbation in patients with alzheimer's disease Pending 29-Jun-2022
WO-2024006939-A2 Systems and methods to characterize individual response to brain perturbation in patients with alzheimer's disease Inactive 29-Jun-2022 A61B5/377
To view Sinaptica Therapeutics’s complete patent history, request access »

Sinaptica Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sinaptica Therapeutics Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
1004 Venture Partners Venture Capital Minority
Asymmetry Ventures Venture Capital Minority
Bootstrap Venture Partners Venture Capital Minority
Device of Tomorrow Capital Venture Capital Minority
Ligo Partners Family Office
You’re viewing 5 of 19 investors. Get the full list »

Ready to get started?

Request a free trial

Sinaptica Therapeutics FAQs

  • When was Sinaptica Therapeutics founded?

    Sinaptica Therapeutics was founded in 2021.

  • Where is Sinaptica Therapeutics headquartered?

    Sinaptica Therapeutics is headquartered in Cambridge, MA.

  • What is the size of Sinaptica Therapeutics?

    Sinaptica Therapeutics has 16 total employees.

  • What industry is Sinaptica Therapeutics in?

    Sinaptica Therapeutics’s primary industry is Therapeutic Devices.

  • Is Sinaptica Therapeutics a private or public company?

    Sinaptica Therapeutics is a Private company.

  • What is Sinaptica Therapeutics’s current revenue?

    The current revenue for Sinaptica Therapeutics is .

  • How much funding has Sinaptica Therapeutics raised over time?

    Sinaptica Therapeutics has raised $35.6M.

  • Who are Sinaptica Therapeutics’s investors?

    1004 Venture Partners, Asymmetry Ventures, Bootstrap Venture Partners, Device of Tomorrow Capital, and Ligo Partners are 5 of 19 investors who have invested in Sinaptica Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process